The project objective is to evaluate the impact of the recent addition of pharmacists within family medicine groups (FMGs) on organizational and clinical parameters. The process by which changes occur and the level of pharmacists' activities will also be assessed. The ultimate goal of the project is the development of an accompanying guide to facilitate the work of the pharmacist in monitoring complex patients in primary care medical clinics.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
62
Pharmacists will make a clinical intervention with patients. They will review patient drug therapy already prescribed in their usual care. This includes a medication reconciliation, an assessment of drug related problems, an assessment of the regimen complexity and adherence to treatment. A care plan will be elaborated. Moreover, immediate and future interventions with the patient or other health professionals will be implemented and monitored. There will be no drug or devices tested, it is a human clinical intervention by a pharmacist.
CIUSSS de la Capitale-Nationale
Québec, Quebec, Canada
Number of drug related problems
Time frame: 3 to 6 months
Regimen complexity
Medication regimen complexity index (MRCI)
Time frame: 3 to 6 months
Medication adherence
Proportion of days covered (PDC)
Time frame: 3 to 6 months
Quality of care provided by the clinical team (pharmacists, doctors, nurses, etc.)
Quality indicators (proposed by INESSS)
Time frame: 3 to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.